» Articles » PMID: 37904429

Expression of MMP-14 and Its Role in Bone Destruction in Middle Ear Cholesteatoma: A Prospective Observational Study

Overview
Specialty General Medicine
Date 2023 Oct 31
PMID 37904429
Authors
Affiliations
Soon will be listed here.
Abstract

Cholesteatoma is a noncancerous cystic lesion caused by an abnormal growth of keratinizing squamous epithelium which is invasive and capable of destroying structures. A prospective study on the expression of membrane type1-matrix metalloproteinases (MMP-14) and its related influencing factors in middle ear cholesteatoma was conducted to fully understand the pathogenesis of cholesteatoma in the molecular level. We examined the expression of MMP-14 by immunohistochemical staining 39 middle ear cholesteatoma specimens and 10 external auditory meatus epithelial cell specimens. The cholesteatoma specimens were divided into 4 groups according to the degree of destruction of the ossicles during surgery. The associated factors affecting MMP-14 expression were analyzed using statistical methods; The positive expression of MMP-14 in the epithelium of the external auditory canal was significantly different between middle ear cholesteatoma and normal patients (P < .05); Gender, age, and the degree of hearing loss had no statistically significant effect on MMP-14 expression (P > .05); The expression of MMP-14 was positively correlated with the severity of bone destruction (R = 0.535, P < .05); MMP-14 plays an important role in the pathological development of the epithelium of cholesteatoma; MMP-14 expression in middle ear cholesteatoma tissue was not strongly correlated with the level of hearing loss, age or gender, but was positively correlated with the degree of middle ear bone destruction.

Citing Articles

Expression of periostin in the epithelium of cholesteatoma with different degrees of ossicular chain destruction and its clinical value in predicting postoperative hearing recovery.

Xie C, Jia X, Ding S, Ding X, Wang G, Liu H Biomed Eng Online. 2024; 23(1):125.

PMID: 39614252 PMC: 11607934. DOI: 10.1186/s12938-024-01319-8.


PTHrP participates in the bone destruction of middle ear cholesteatoma via promoting macrophage differentiation into osteoclasts induced by RANKL.

Xie S, Jin L, Fu J, Yuan Q, Yin T, Ren J Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024; 49(5):655-666.

PMID: 39174879 PMC: 11341230. DOI: 10.11817/j.issn.1672-7347.2024.230482.